跳至主要内容
临床试验/CTRI/2024/01/060994
CTRI/2024/01/060994尚未招募不适用

A prospective observational study to assess serum magnesium level and its correlation with ESA responsiveness in anemia in CKD patients at a tertiary care hospital in Uttarakhand

BHAWNA SAINI1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2024年1月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
121
试验地点
1
主要终点
•To study the serum magnesium level in CKD stage 3-5 patients

研究概览

简要总结

The purpose of this study is to assess serum magnesium level in chronic kidney disease (CKD) patients and establish it’s correlation with Erythropoiesis-stimulating agents (ESA) responsiveness in anemia in CKD patients. Low level of Serum Magnesium can increase requirement of higher doses of ESAs drugs for treatment of anemia in CKD. Establishment of association of serum Magnesium and ESAs hyporesponsiveness can help to correct serum Magnesium levels at early stages of CKD to reduce need of ESAs administration.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Age 18-70 years of either sex
  • Patients that have CKD Stage-3-5.

排除标准

  • Infectious disease
  • Active liver disease
  • Neoplastic disease on cytotoxic chemotherapy
  • Recent cardio-cerebrovascular disease
  • Blood transfusions or surgical procedures within last 4 weeks
  • Active bleeding or pure red cell aplasia
  • Patients receiving phosphate binder containing magnesium or laxatives containing magnesium.

结局指标

主要结局

•To study the serum magnesium level in CKD stage 3-5 patients

时间窗: •To study the serum magnesium level in CKD stage 3-5 patients

次要结局

  • To correlate serum magnesium level with the severity of anemia(BASELINE (DAY-1) AND AFTER 1 MONTH)
  • To correlate serum magnesium level with the erythropoiesis stimulating agents responsiveness in the anemia in chronic kidney disease patient(BASELINE (DAY-1) AND AFTER 1 MONTH)
  • To identify adverse drug reactions associated with erythropoiesis stimulating agents responsiveness in the anemia in chronic kidney disease patient(BASELINE (DAY-1) AND AFTER 1 MONTH)

研究者

发起方
BHAWNA SAINI
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Bhawna Saini

AIIMS, RISHIKESH

研究点 (1)

Loading locations...

相似试验

A clinical study to assess response of a drug that... | 临床试验